Saslow D, Castle PE, Cox JT, Davey DD, Einstein MH, Ferris DG, Goldie SJ, HarperDM, Kinney W, Moscicki AB, Noller KL, Wheeler CM, Ades T, Andrews KS, DoroshenkMK, Kahn KG, Schmidt C, Shafey O, Smith RA, Partridge EE, Garcia F.
University of Arizona National Center of Excellence in Women's Health and theArizona Hispanic Center of Excellence, Tucson, AZ.
The American Cancer Society (ACS) has developed guidelines for the use of the prophylactic human papillomavirus (HPV) vaccine for the prevention of cervical intraepithelial neoplasia and cervical cancer. These recommendations are basedon a formal review of the available evidence. They address the use of prophylactic HPV vaccines, including who should be vaccinated and at what age, as well as a summary of policy and implementation issues. Implications for screening are also discussed.
